| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9978721 | The Journal of Thoracic and Cardiovascular Surgery | 2005 | 4 Pages |
Abstract
In pulmonary neuroendocrine tumors cell type is the predominant determinant of survival. The survival of patients with each cell type is sufficiently diverse to warrant different management strategies. Conservative resection is feasible for typical carcinoids, but the effects of adjuvant chemotherapy need to be evaluated for the other subgroups.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Eric MRCS, Yoong K. MRCS, Bianca L. PhD, Andrew G. MRCPath, Peter (FRCS),